Showing results (1-10 of 4,510) with videos related to
Sort By:
Pageof 451
Frontiers in Immunology|April 26, 2018
New Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune CellsNancy Gupta, Rakesh Kumar, Babita AgrawalVaccine|October 4, 2016
Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacyNancy Gupta, Satish Vedi, Dennis Y Kunimoto, et al.Cells|July 13, 2026
A Novel Host-Based Immunotherapy for the Suppression of HBV and HCV Replication: Heat-Killed <i>Caulobacter crescentus</i> (HKCC)Raj S Patel, Nancy Gupta, Satish Vedi, et al.International Journal of Molecular Sciences|July 28, 2017
Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another DimensionBabita Agrawal, Shakti Singh, Nancy Gupta, et al.World Journal of Gastroenterology|July 20, 2016
Symbiotic chemo- and immuno-therapy for hepatitis B and C virusesBabita Agrawal, Rakesh KumarCurrent Opinion in Investigational Drugs (London, England : 2000)|March 27, 2004
Novel treatment options for hepatitis B virus infectionRakesh Kumar, Babita AgrawalFrontiers in Immunology|November 3, 2018
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit VaccineNancy Gupta, Saurabh Garg, Satish Vedi, et al.Cells|May 28, 2019
Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV AntigensBabita Agrawal, Nancy Gupta, Satish Vedi, et al.Frontiers in Immunology|November 9, 2018
MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T CellsBabita Agrawal, Nancy Gupta, Jeffrey D KonowalchukCells|February 25, 2023
Harnessing Innate Immunity to Treat <i>Mycobacterium tuberculosis</i> Infections: Heat-Killed <i>Caulobacter crescentus</i> as a Novel BiotherapeuticNancy Gupta, Satish Vedi, Saurabh Garg, et al.Pageof 451